{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "Seven patients were implanted"
      },
      "Intervention": {
        "score": 2,
        "evidence": "implanted with and underwent semichronic recording from the NeuroPort\u2122 array during standard subdural electrode monitoring for epilepsy"
      },
      "Objective": {
        "score": 1,
        "evidence": "We describe our initial surgical experience with the NeuroPort\u2122 MEA in a series of patients undergoing subdural electrode implantation for epilepsy monitoring."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Robust and durable LFPs and single-unit recordings were obtained from all implanted individuals."
      },
      "Harms": {
        "score": 1,
        "evidence": "There were no neurological complications or infections associated with electrode implantation or prolonged monitoring."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 6,
    "max_score": 25
  },
  "model": "gpt-4o"
}